Comprehensive Treatment of Trans-Arterial Chemoembolization Plus Lenvatinib Followed by Camrelizumab for Advanced Hepatocellular Carcinoma Patients

Aim: This study aimed to report the efficacy and safety of trans-arterial chemoembolization (TACE) plus lenvatinib and camrelizumab in patients with advanced hepatocellular carcinoma (HCC).Methods: This retrospective study enrolled 22 patients with advanced HCC from March 2018 to December 2019. All...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Juanfang Liu, Zhen Li, Wenguang Zhang, Huibin Lu, Zhanguo Sun, Guozheng Wang, Xinwei Han
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2021-10-01
Colecção:	Frontiers in Pharmacology
Assuntos:	hepatocellular carcinoma TACE lenvatinib camrelizumab intervention therapy
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2021.709060/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!